Type 1 diabetes, a disorder in which the immune system attacks insulin-producing cells, has long been difficult to treat effectively. However, researchers at Johns Hopkins Medicine discovered a potential game-changer: mAb43, a novel antibody medication designed to prevent and potentially reverse Read More...
Monitoring blood sugar and administering insulin throughout the day is no easy task, but for kids busy learning and playing, or too young to manage the process without a parent's help, it’s even more difficult. Fortunately, the FDA has approved the first automated insulin system for young Read More...